Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.

Deguchi S, Yamashita T, Igai K, Harada K, Toba Y, Hirata K, Takayama K, Mizuguchi H.

Drug Metab Dispos. 2019 Jun;47(6):632-638. doi: 10.1124/dmd.119.086322. Epub 2019 Apr 8.

PMID:
30962288
2.

Ectosymbiotic bacterial microbiota densely colonize the surface of thelastomatid nematodes in the gut of the wood-feeding cockroach Panesthia angustipennis.

Murakami T, Onouchi S, Igai K, Ohkuma M, Hongoh Y.

FEMS Microbiol Ecol. 2019 Feb 1;95(2). doi: 10.1093/femsec/fiy238.

PMID:
30561598
3.

Genome analyses of uncultured TG2/ZB3 bacteria in 'Margulisbacteria' specifically attached to ectosymbiotic spirochetes of protists in the termite gut.

Utami YD, Kuwahara H, Igai K, Murakami T, Sugaya K, Morikawa T, Nagura Y, Yuki M, Deevong P, Inoue T, Kihara K, Lo N, Yamada A, Ohkuma M, Hongoh Y.

ISME J. 2019 Feb;13(2):455-467. doi: 10.1038/s41396-018-0297-4. Epub 2018 Oct 4.

PMID:
30287885
4.

A High Burden of Asymptomatic Gastrointestinal Infections in Traditional Communities in Papua New Guinea.

Horwood PF, Soli KW, Maure T, Naito YI, Morita A, Natsuhara K, Tadokoro K, Baba J, Odani S, Tomitsuka E, Igai K, Larkins JA, Siba PM, Pomat W, McBryde ES, Umezaki M, Greenhill AR.

Am J Trop Med Hyg. 2017 Dec;97(6):1872-1875. doi: 10.4269/ajtmh.17-0282. Epub 2017 Sep 21.

5.

Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system.

Takayama K, Igai K, Hagihara Y, Hashimoto R, Hanawa M, Sakuma T, Tachibana M, Sakurai F, Yamamoto T, Mizuguchi H.

Nucleic Acids Res. 2017 May 19;45(9):5198-5207. doi: 10.1093/nar/gkx130.

6.

Nitrogen fixation and nifH diversity in human gut microbiota.

Igai K, Itakura M, Nishijima S, Tsurumaru H, Suda W, Tsutaya T, Tomitsuka E, Tadokoro K, Baba J, Odani S, Natsuhara K, Morita A, Yoneda M, Greenhill AR, Horwood PF, Inoue J, Ohkuma M, Hongoh Y, Yamamoto T, Siba PM, Hattori M, Minamisawa K, Umezaki M.

Sci Rep. 2016 Aug 24;6:31942. doi: 10.1038/srep31942.

7.

Association of protein intakes and variation of diet-scalp hair nitrogen isotopic discrimination factor in Papua New Guinea highlanders.

Naito YI, Morita A, Natsuhara K, Tadokoro K, Baba J, Odani S, Tomitsuka E, Igai K, Tsutaya T, Yoneda M, Greenhill AR, Horwood PF, Soli KW, Phuanukoonnon S, Siba PM, Umezaki M.

Am J Phys Anthropol. 2015 Nov;158(3):359-70. doi: 10.1002/ajpa.22798. Epub 2015 Jul 14.

PMID:
26173929
8.

Development, validation, and use of a semi-quantitative food frequency questionnaire for assessing protein intake in Papua New Guinean Highlanders.

Morita A, Natsuhara K, Tomitsuka E, Odani S, Baba J, Tadokoro K, Igai K, Greenhill AR, Horwood PF, Soli KW, Phuanukoonnon S, Siba PM, Umezaki M.

Am J Hum Biol. 2015 May-Jun;27(3):349-57. doi: 10.1002/ajhb.22647. Epub 2014 Nov 3.

PMID:
25367668
9.

A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin.

Nishikawa K, Watanabe M, Kita E, Igai K, Omata K, Yaffe MB, Natori Y.

FASEB J. 2006 Dec;20(14):2597-9. Epub 2006 Oct 25.

PMID:
17065223
10.

Development of dialyzer with immobilized glycoconjugate polymers for removal of Shiga-toxin.

Miyagawa A, Watanabe M, Igai K, Kasuya MC, Natori Y, Nishikawa K, Hatanaka K.

Biomaterials. 2006 Jun;27(17):3304-11. Epub 2006 Feb 24.

PMID:
16499963
11.

Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues.

Watanabe M, Igai K, Matsuoka K, Miyagawa A, Watanabe T, Yanoshita R, Samejima Y, Terunuma D, Natori Y, Nishikawa K.

Infect Immun. 2006 Mar;74(3):1984-8.

12.

Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation.

Nishikawa K, Matsuoka K, Watanabe M, Igai K, Hino K, Hatano K, Yamada A, Abe N, Terunuma D, Kuzuhara H, Natori Y.

J Infect Dis. 2005 Jun 15;191(12):2097-105. Epub 2005 May 11.

PMID:
15897996
13.

Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.

Watanabe M, Matsuoka K, Kita E, Igai K, Higashi N, Miyagawa A, Watanabe T, Yanoshita R, Samejima Y, Terunuma D, Natori Y, Nishikawa K.

J Infect Dis. 2004 Feb 1;189(3):360-8. Epub 2004 Jan 21.

PMID:
14745692

Supplemental Content

Support Center